EUVIMEDEUVIMED entdecken
Open Access

The anticancer effects of PCAIs in pancreatic cancer cells involve MAPK and PI3K/AKT pathways hyperactivation

Kweku Ofosu-Asante, Jassy Mary S Lazarte, Amarender Goud Burra, Nazarius S Lamango

Oncotarget · 03.06.2026 · 17 (1) · 268-290

DOI: 10.18632/oncotarget.28879 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncotarget, erschienen am 03.06.2026. Verfasst von Kweku Ofosu-Asante und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Proto-Oncogene Proteins c-akt, Phosphatidylinositol 3-Kinases, Antineoplastic Agents. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIMHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsProto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesAntineoplastic AgentsMitogen-Activated Protein KinasesHumansCell Line, TumorSignal TransductionApoptosisProto-Oncogene Proteins p21(ras)Cell ProliferationMAP Kinase Signaling SystemPhosphorylationCell Survival

Stichwörter der Autor:innen

KRASMAPKPCAIsPDACPI3K/AKT

Substanzen

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesAntineoplastic AgentsProto-Oncogene Proteins p21(ras)KRAS protein, humanMitogen-Activated Protein Kinases

Förderung

  • NCI NIH HHS
  • NIMHD NIH HHS

Zitieren

APA

Ofosu-Asante, K., Lazarte, J. M. S., Burra, A. G., & Lamango, N. S. (2026). The anticancer effects of PCAIs in pancreatic cancer cells involve MAPK and PI3K/AKT pathways hyperactivation. Oncotarget, 17(1), 268-290. https://doi.org/10.18632/oncotarget.28879

Vancouver

Ofosu-Asante K, Lazarte JMS, Burra AG, Lamango NS. The anticancer effects of PCAIs in pancreatic cancer cells involve MAPK and PI3K/AKT pathways hyperactivation. Oncotarget. 2026;17(1):268-290. doi:10.18632/oncotarget.28879

BibTeX
@article{OfosuAsante2026,
  author = {Ofosu-Asante, Kweku and Lazarte, Jassy Mary S and Burra, Amarender Goud and Lamango, Nazarius S},
  title = {The anticancer effects of PCAIs in pancreatic cancer cells involve MAPK and PI3K/AKT pathways hyperactivation},
  journal = {Oncotarget},
  year = {2026},
  volume = {17},
  number = {1},
  pages = {268--290},
  doi = {10.18632/oncotarget.28879}
}
Kostenlos starten →